4
Wake
&
REM:
Monoamines
Neurobiology of Sleep
and Wakefulness
Learning Points & Defining Behavioral States
Historical Overview: Brainstem & Forebrain
Wakefulness and REM Sleep: Monoamines,
Acetylcholine & GABA, Hypocretin/Orexin
NREM Sleep: GABA, Adenosine
Summary
NREM
REM
Jacobs and Fornal, in Handbook of Behavioral State Control, CRC Press 1999, p. 184
500 V
EEG
500 V
Unit
1 mV
Quiet Waking
HDC -/-
State-Specific Changes in
Brain Levels of Monoamines
In every brain region studied, levels of serotonin,
norepinephrine, and histamine are greater during
wakefulness than during sleep
Wakefulness
NREM Sleep
REM Sleep
Monoamines Promote
Wakefulness: Clinical Relevance
Selective serotonin (SSRIs) and serotoninnorepinephrine (SNRIs) enhance the actions of these
two wake-promoting neurotransmitters
SSRIs and SNRIs are widely used for the treatment of
depression
Insomnia or disturbed sleep are common side effects
of SSRIs and SNRIs
Monoamines Promote
Wakefulness: Clinical Relevance
Patients with major depressive disorder often
have coexisting insomnia that does not
improve with antidepressant treatment
Combining the use of an SSRI (fluoxetine) with
a sleeping medication (eszopiclone) increases
the antidepressant response and improves
sleep (Fava et al., Biol Psychiatry 59:1052-1060, 2006)
Monoamines Promote
Wakefulness: Clinical Relevance
Doxepin improves sleep in adults
and
with primary